PCR detects fungal DNA in keratitis

Article

Polymerase chain reaction (PCR) could be used to diagnose fungal keratitis.

Polymerase chain reaction (PCR) could be used to diagnose fungal keratitis, claims an investigation in the journal Eye.

A team led by Dr N. Tananuvat, Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, conducted a prospective nonrandomized study on 30 eyes of 30 patients with presumed fungal keratitis.

Each patient underwent corneal scraping and fungal-specific primers were used to analyse the specimens. PCR products were cloned and sequenced and compared to conventional microbial work-up.

PCR demonstrated positivity in 93.3%, culture in 40% and potassium hydroxide in 20% of the total patients included in the study. Out of the 28 PCR-positive patients, 12 were culture-positive and 16 were culture-negative.

There were no false-negative results in the culture-positive specimens recorded by the PCR, suggesting it is able to accurately detect fungal DNA in a high percentage of culture-negative cases. The procedure could be helpful, in addition to smear and culture in the efficient diagnosis of fungal keratitis.

Please click here to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.